Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00221442 · ClinicalTrials.gov registry record · Phase 3
Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity
A Phase 3 study, sponsored by Lindner Center of HOPE.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
NCT00221442 is a Phase 3 study that has completed, run by Lindner Center of HOPE. The registered enrollment target is 60 participants.
The verdict
NCT00221442, a Phase 3 study, has completed, sponsored by Lindner Center of HOPE.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
Study Summary
The specific aim of this study is to examine the efficacy and safety of zonisamide compared with placebo in outpatients with binge eating disorder associated with obesity.
Interventions
- DRUG sugar pill
- DRUG Zonegran
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2005-08 |
| Est. Completion | 2009-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00221442
The ClinicalTrials.gov registry entry for NCT00221442 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindner Center of HOPE, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sugar pill is the first listed.
NCT00221442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00221442 about?
NCT00221442 is a clinical study titled "Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity". The specific aim of this study is to examine the efficacy and safety of zonisamide compared with placebo in outpatients with binge eating disorder associated with obesity.
What is the current status of trial NCT00221442?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2005-08. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00221442?
The interventions under investigation include: sugar pill (DRUG), Zonegran (DRUG).
Who is sponsoring clinical trial NCT00221442?
This trial is sponsored by Lindner Center of HOPE, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.